Micro-Leads
Mark Klopp is currently an advisor for Business Development at Micro-Leads. Prior to this, they were a Co-Founder, Board Member, Investor, and VP of Business Development at Uptake Medical from February 2005 to May 2006. The company was acquired by Broncus in 2016. From June 1999 to December 2004, Klopp was the Managing Director of Eastman Ventures, the corporate venture capital arm of Eastman Chemical Company.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Micro-Leads
Micro-Leads Medical is a medical technology company dedicated to an innovative targeted neuromodulation delivery platform. Micro-Leads is using disruptive technology to initially provide high-resolution, targeted epidural spinal cord stimulation for chronic pain with a pipeline of other indications.